Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00003827 · UNKNOWN

Trial details

NCT number: NCT00003827
Sponsor: ALZA
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes

Start date: 1999-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.